1-Methyl-4-(3-phenyl-propyl)-piperazine

ID: ALA351230

PubChem CID: 12563600

Max Phase: Preclinical

Molecular Formula: C14H22N2

Molecular Weight: 218.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCc2ccccc2)CC1

Standard InChI:  InChI=1S/C14H22N2/c1-15-10-12-16(13-11-15)9-5-8-14-6-3-2-4-7-14/h2-4,6-7H,5,8-13H2,1H3

Standard InChI Key:  VDMPTTZAUYEXDG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -1.0500   -0.1417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500   -0.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1583   -0.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1458    0.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7500   -0.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7458    0.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6500   -0.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8458    0.9083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500   -0.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9500    0.3833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5500    0.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4458    0.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5458    1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7375    1.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8375    1.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4333    1.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  1  1  0
  6  1  1  0
  7  1  1  0
  8 11  1  0
  9  2  1  0
 10  7  1  0
 11 10  1  0
 12  8  2  0
 13  8  1  0
 14 12  1  0
 15 13  2  0
 16 15  1  0
  3  2  1  0
 14 16  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

DRD2 Tclin Dopamine receptor (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 218.34Molecular Weight (Monoisotopic): 218.1783AlogP: 1.87#Rotatable Bonds: 4
Polar Surface Area: 6.48Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.45CX LogP: 2.49CX LogD: 1.41
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.76Np Likeness Score: -1.06

References

1. Glennon RA, Salley JJ, Steinsland OS, Nelson S..  (1981)  Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists.,  24  (6): [PMID:7252977] [10.1021/jm00138a007]

Source